The enzyme involved in the reduction of D 1 -piperideine-6-carboxylate (P6C) to L-pipecolic acid (L-PA) has never been identiˆed. We found that Escherichia coli JM109 transformed with the lat gene encoding L-lysine 6-aminotransferase (LAT) converted L-lysine (L-Lys) to L-PA. This suggested that there is a gene encoding``P6C reductase'' that catalyzes the reduction of P6C to L-PA in the genome of E. coli. The complementation experiment of proC32 in E. coli RK4904 for L-PA production clearly shows that the expression of both lat and proC is essential for the biotransformation of L-Lys to L-PA. Further, We showed that both LAT and pyrroline-5-carboxylate (P5C) reductase, the product of proC, were needed to convert L-Lys to L-PA in vitro. These results demonstrate that P5C reductase catalyzes the reduction of P6C to L-PA. Biotransformation of L-Lys to L-PA using latexpressing E. coli BL21 was done and L-PA was accumulated in the medium to reach at an amount of 3.9 g W l after 159 h of cultivation. It is noteworthy that the ee-value of the produced pipecolic acid was 100%.
L-Pipecolic acid (L-PA) is an amino acid not observed in proteins, and is an important component and a precursor of many microbial and plant secondary metabolites such as immunosuppressants, 1) peptide antibiotics, 2) and piperideine alkaloids.
3) The biosynthesis of L-PA has been investigated in terms of L-lysine (L-Lys) metabolism for a long time. It has been known that L-PA is synthesized biologically by the deaminative cyclization of L-Lys, by the reduction of D 1 -piperideine-2-carboxylate (P2C), or by the reduction of D 1 -piperideine-6-carboxylate (P6C). In Streptomyces hygroscopicus, which produces rapamycin, an immunosuppressant containing L-PA as a component, lysine cyclodeaminase catalyses the deaminative cyclization of L-Lys to L-PA.
1) The rapL gene encoding lysine cyclodeaminase is located in the gene cluster for rapamycin. 4) In Pseudomonas putida, L-Lys is initially converted to D-lysine, metabolized to P2C, and then P2C is converted to L-PA by P2C reductase. 5) P6C, which is the reversible cyclic form of a-aminoadipic semialdehyde, was identiˆed as the product of the deamination of L-Lys that was catalyzed by L-lysine 6-aminotransferase (LAT, E.C.2.6.1.36) in Flavobacterium lutescens IFO3084 6) and b-lactam-producing actinomycetes 7) (Fig. 1 ). In addition, P6C is also produced from L-Lys by lysine 6-dehydrogenase in Agrobacterium tumefaciens 8) and from saccharopine by saccharopine oxidase (EC 1.5.1.10) in Rhizoctonia leguminicola.
9) The activity of the reduction of P6C to L-PA was found in cellfree enzyme systems of microorganisms. 9) However, no information about the enzyme involved in the reduction of P6C has been ever obtained, because the substrate, P6C, is chemically unstable and the lack of available P6C precluded the characterization of the enzyme.
We have investigated the biosynthesis of L-aaminoadipic acid (L-AAA) from L-Lys in F. lutescens IFO3084 and cloned the lat gene encoding LAT and the pcd gene encoding P6C dehydrogenase from F. lutescens IFO3084. 10, 11) Our next attention was focused on the``P6C reductase'' that catalyzes the reduction of P6C to L-PA to produce L-PA from LLys. We found that``P6C reductase'' exists in Escherichia coli. Further our works in vivo and in vitro demonstrate that the enzyme is pyrroline-5-carboxylate (P5C) reductase (EC 1.5.1.2) encoded by proC, which catalyzes the reduction of D 1 -pyrroline-5-carboxylate to L-proline and is found in almost all organisms. 12, 13) In this paper we describe the reduction of P6C to L-PA catalyzed by P5C reductase and the biotransformation of L-Lys to L-PA using lat-expressing E. coli. 
Materials and Methods
Bacterial strains. E. coli JM109 was used for the isolation of chromosomal DNA and the production of L-PA. E. coli RK4904 (CGSC#: 6404), which is a proC32 mutant obtained from the E. coli Genetic Stock Center (Yale University, USA), was used as the host strain for a complementation experiment of proC32. E. coli TOP10 (Invitrogen) was used for protein expression. E. coli BL21 was used as the host strain for the production of L-PA.
Construction of plasmids.
A lat-expressing plasmid pRH124 was constructed as follows: using F. lutescens IFO3084 chromosomal DNA as a template, a 1571-bp fragment containing lat was ampliˆed by PCR. The primers were designed on the basis of the sequence of lat and contained a 5? HindIII site in primer I (5?-ATAAGCTTGTCCCTTCTTGCCC-CGCTCGC-3?) and a 5? BamHI site in the primer II (5?-GCGGATCCTGTTGCCGCTGGTGCCGGGC-AG-3?). The ampliˆed PCR product was digested with HindIII and BamHI, and ligated into HindIIIBamHI-digested pUC19. A lat and proC expressing plasmid pRH134 was constructed as follows: using E. coli JM109 chromosomal DNA as a template, a 1443-bp fragment containing proC was ampliˆed by PCR with the primers that contained a 5? KpnI site in each (5?-CCGGTACCATAAAATCGCGCATCGT-CAGGC-3? and 5?-CCGGTACCGCCACAGGTAA-CTTTACGGATT-3?). The KpnI digested PCR product was ligated into the KpnI site of pRH124. A proC-expressing plasmid pRH135 was also constructed as follows: pRH134 was digested with HindIII and BamHI,ˆlled with T4 polymerase, and self-ligated with T4 ligase. A proC-expressing plasmid pTrcP5CR was constructed as follows: two primers, primer EX1 and primer EX2, were prepared for PCR to obtain proC. Primer EX1 was designed on the basis of the N-terminal sequence of proC and contained a 5? BamHI site (5?-ATGGATCCG-AAAATCGGTTTTATTGGCT-3?). Primer EX2 was designed on the basis of the C-terminal sequence of proC and contained a 5? EcoRI site (5?-TCGAAT-TCCAGGATTTGCTGAGTTTTTCT-3?). Using E. coli JM109 chromosomal DNA as a template, an ampliˆcation by PCR was done. The PCR product was digested with BamHI and EcoRI and then ligated into pTrcHis2A (Invitrogen) digested with BamHI and EcoRI. The resulting plasmid was designated as pTrcP5CR.
Expression of lat in E. coli JM109. E. coli JM109 harboring pRH124 was cultivated at 329 C with shaking in L-broth (polypeptone 1.0z, yeast extract 0.5z, NaCl 0.5z, glucose 0.1z, pH 7.2) containing 50 mg of ampicillin sodium per ml. Thirty ml of overnight-grown culture was added to 3 ml of L-broth containing 50 mg ampicillin sodium per ml. The culture was grown at 329 C with shaking, and the expression of LAT was induced by the addition of isopropyl-b-D-thiogalactopyranoside (IPTG) (1 mM, nal concentration) when the absorbance at 660 nm of the culture reached 1.0. After 4 h of cultivation, 30 ml of 50z glycerol and 30 ml of 50z L-lysine HCl were added to the culture, and the culture was cultivated for 15 h more. The supernatants of these cultures were analyzed by TLC and HPLC to estimate the amount of L-PA.
Complementation experiment of proC32. E. coli RK4904 harboring pUC19, pRH124, pRH134, or pRH135 was cultivated at 329 C with shaking in Lbroth containing 50 mg of ampicillin sodium per ml. Two hundred and seventyˆve ml of the broth was added to 25 ml of TB (polypeptone 3.2z, yeast extract 2.4z, glycerol 0.4z, 100 mM phosphate buŠer (pH 7.4)) containing 50 mg ampicillin sodium per ml. After 8 h of cultivation, 500 ml of 50z glycerol and 500 ml of 50z L-lysine HCl were added to the culture broth and the cultivation was continued for 40 h more. The supernatants of these cultures were analyzed by TLC and HPLC to estimate the amount of L-PA.
Fermentation experiment. E. coli BL21 harboring pRH124 was cultured in the same manner as the cultivation of E. coli RK4904 described above. One hundred ml of each culture was collected after 15, 39, 63, 87, 111 and 159 h of cultivation.
Expression and puriˆcation of recombinant proteins. Recombinant LAT and recombinant P5C reductase were expressed and puriˆed using E. coli TOP10 W pTrcLAT and E. coli TOP10 W pTrcP5CR, respectively, by the method described previously. 10) Cooperative enzymatic transformation of L-Lys to L-PA in vitro. Reaction mixture contained 0.2 mmol of sodium phosphate buŠer (pH 7.2), 1 mmol of Llysine HCl, 10 mmol of 2-ketoglutarate, 37.5 pmol of pyridoxsal phosphate, 2 mmol of NADPH, 1 mg of LAT, and 5 mg of P5C reductase in aˆnal volume of 1 ml. The reaction mixture was incubated at 329 C. At regular times, a sample (100 ml) of the reaction mixture was collected and added 900 ml of acetonitrile W water (5:4) to stop the enzymatic reactions. The amounts of L-Lys and L-PA in the reaction mixture were measured by ESI LC W MS.
TLC analysis. The culture broth was centrifuged and the resulting supernatant was used for quantitative analysis with TLC as described previously.
11)
HPLC analysis. Pipecolic acid and lysine were labeled with 14) and the L-FDLA derivatives of pipecolic acid and lysine were analyzed by HPLC on a YMC-Pack s-5 60A ODS (4.6×150 mm) column maintained at 359 C using a acetonitrile concentration gradient in 1z acetic acid aqueous solution from 40z to 80z for 20 minutes with a ‰ow rate of 1.0 ml per minute. The derivatives were detected by UV-monitoring at 340 nm. The enantiomeric purity of pipecolic acid was also determined by this HPLC method.
LC W MS analysis. The cooperative enzymatic transformation from L-Lys to L-PA by LAT and P5C reductase was monitored by liquid chromatography W mass spectrometry (LC W MS). HPLC conditions were as follows: column, YMC J's phere ODS (4.5× 75 mm); mobile phase, methanol W 2 mM ammonium acetate solution containing 5 mM nona‰uorovaleric acid (30:70); ‰ow rate, 0.5 ml W minute; column temperature, 359 C. The mass spectrometer used was a Finnigan AQA (Thermo Quest, UK). The protonated molecules [M+H] + of L-Lys and L-PA were detected in positive ion mode to give peaks at m W z 147 and 130, respectively. Under these LC W MS conditions, the retention times of L-PA and L-Lys were 4.01 and 6.72 min, respectively.
Results

Production of L-PA by E. coli transformed with lat gene
In the course of our studies on pcd, we found that the pcd deˆcient mutant of F. lutescens IFO3084 slightly converted L-Lys to L-PA in phosphate buŠer (pH 7.0) containing L-Lys and glycerol (data not shown). This result suggested that there is the gene in the genome of F. lutescens IFO3084 encoding``P6C reductase'' that catalyzes the reduction of P6C to L-PA. To clone the gene encoding``P6C reductase'', weˆrst tried to construct the gene library of F. lutescens IFO3084, introduce the gene library into lat-expressing E. coli JM109 W pRH124, and isolate the clone in which L-Lys is converted to L-PA. However, to our surprise, E. coli JM109 W pRH124 itself converted L-Lys to L-PA (Fig. 2A) . Since LAT catalyzes the conversion of L-Lys to P6C, 6, 10) this result implies that there is a gene encoding another`P 6C reductase'' also in the genome of E. coli JM109.
Complementation of proC32 for L-PA production The structural similarity between P6C and P5C brought us an idea that``P6C reductase'' may be similar to P5C reductase. However, we failed toˆnd any additional protein with high similarity to P5C reductase in E. coli by a BLAST search (data not shown), suggesting that P5C reductase itself catalyzes the reduction of P6C as well as P5C. To examine whether P5C reductase catalyzes the reduction of P6C to L-PA, we did a complementation experiment of proC32, a mutation of proC encoding P5C reductase. We transformed E. coli RK4904 ( proC32) with pUC19, a lat expression plasmid pRH124, a lat and proC expression plasmid pRH134, or a proC expression plasmid pRH135, and cultured these transformants in TB added with L-Lys. L-PA was not detected by TLC and HPLC analysis in the culture broth of E. coli RK4904 W pUC19 (lat " , proC "
), E. coli RK4904 W pRH124 (lat + , proC " ), and E. coli RK4904 W pRH135 (lat " , proC + ) (Fig. 2(B) ). On the other hand, L-PA was detected in the culture broth of E. coli RK4904 W pRH134 (lat + , proC + ) (Fig. 2(B) ). These results clearly show that the expression of both lat and proC is essential for the biotransformation of L-Lys to L-PA.
Reduction of P6C to L-PA by P5C reductase To verify that P5C reductase, the proC gene product, catalyzes the reduction of P6C to L-PA in vitro, we tried the cooperative enzymatic transformation of L-Lys to L-PA by LAT and P5C reductase. First, proC of E. coli JM109 was ampliˆed and ligated into pTrcHis2A to construct a recombinant P5C reductase expression plasmid of pTrcP5CR. The expressed and puriˆed recombinant P5C reductase gave a single band on SDS-PAGE, corresponding to a molecular mass of about 32 kDa (Fig. 3) , which is in good agreement with the value (31.4 kDa) estimated from the deduced amino acid sequence. By using the recombinant P5C reductase and the recombinant LAT, 10) L-Lys was stoichiometrically converted to L-PA in vitro. Figure 4 shows that the number of moles of consumed L-Lys was almost equal to that of E. coli BL21 W pRH124 was cultured and the amount of L-PA in the culture broth was measured as described in Materials and Methods.
produced L-PA in each incubation time. In addition, the formation of L-glutamate was observed in the reaction mixture (data not shown).
Fermentation experiment for L-PA production We have described above that L-PA was accumulated in the culture broth of lat-expressing E. coli JM109. Further, we transformed E. coli JM109, C600, and BL21 with pRH124 or pRH134 and examined L-PA production using these transformants. We found that E. coli BL21 W pRH124 produced the largest amount of L-PA of these six transformants (data not shown). Then, a fermentation experiment for L-PA production using E. coli BL21 W pRH124 was done. E. coli BL21 W pRH124 was cultured and excessive L-Lys and glycerol were added to the culture medium. L-PA was accumulated in the medium and reached at an amount of 3.9 g W l after 159 h of cultivation (Fig. 5) . The ee-value of the produced pipecolic acid was 100z.
Discussion
We here demonstrated for theˆrst time that the P5C reductase from E. coli catalyzes the reduction of P6C to L-PA by in vivo and in vitro experiments (Fig. 1) . Thisˆnding suggests that in the microorganisms that produce L-PA via P6C from L-Lys, such as R. leguminicola 9) and F. lutescens, P5C reductase is responsible, at least in part, for the reduction of P6C to L-PA, because P5C reductase is present in almost all organisms.
It is di‹cult to analyze quantitatively the enzymatic reaction of P6C, because P6C is chemically unstable, tends to undergo polymerization, and is reversibly converted to a-aminoadipic semialdehyde in aqueous solution. 15, 16) However, our data suggest that following reaction steps are involved in the biotransformation of L-Lys to L-PA:
Step (i) is the known transamination by LAT. 6, 10) Step (ii) is a spontaneous chemical reaction.
Step (iii) is the novel reduction by P5C reductase. The instability of P6C at pH above 5.0 may be the reason why the number of moles of produced L-PA was not completely equal to the number of moles of added L-Lys at the incubation time of 23 h. 15, 16) It is currently unclear why E. coli BL21 W pRH124 produced a larger amount of L-PA than E. coli BL21 W pRH134. It seems possible that in this biotransformation system of L-Lys to L-PA the reduction of P6C to L-PA is not the rate-limiting step and the excess expression of proC has a bad in‰uence.
L-PA is an important compound as a component of many drugs. Recently, much attention has been focused on the importance of chirality as the key to the e‹cacy of many drug products. The current route to the pure enantiomer of pipecolic acid is the classical resolution of the racemate by fractional crystallization of diastereomeric salts 17) or the stereoselective transformation of the racemate by biocatalytical process.
18) However, it is di‹cult to obtain the 100z ee of L-PA. Pipecolic acid produced by our biotransformation system was ( S )-pipecolic acid (L-PA), and its ee-value was 100z. It is noteworthy that our biotransformation of L-Lys to L-PA by the latexpressing E. coli preserved the chirality. On the basis of this biotransformation, highly e‹cient production of L-PA will become possible in the near future.
